Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 21, 2021 | SVP and General Counsel | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,418 | -- | 8,418 | |
| Jul 21, 2021 | SVP and General Counsel | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,418 | -- | 8,418 | |
| Jun 21, 2018 | Director | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 8,456 | $22.40 | 74,671 | |
| Jul 07, 2022 | Director, President and CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 8,574 | $20.54 | 407,313 | |
| Jul 19, 2023 | SVP/GM, Vascular Access | Form 4/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,610 | -- | 56,119 | |
| Oct 30, 2004 | Director, Chief Executive Officer | Form 4 | Other acquisition or disposition (describe transaction) | 8,614 | $9.72 | 8,614 | |
| Jul 20, 2022 | SVP Global Operations and R&D | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,646 | -- | 8,646 | |
| Jul 20, 2022 | SVP/GM, VIT | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,680 | -- | 8,680 | |
| Jul 27, 2007 | SVP - CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,750 | -- | 8,750 | |
| Jul 25, 2014 | EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,759 | -- | 8,759 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.